查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614263

胞外体研究市场：按产品/服务、适应症、应用和最终用户 - 2025-2030 年全球预测

Exosome Research Market by Product & Service (Instruments, Kits & Reagents, Services), Indication (Cancer Indication, Cardiovascular Diseases, Infectious Diseases), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胞外体研究市场价值为2.3098亿美元，预计到2024年将达到2.574亿美元，复合年增长率为11.85%，到2030年将达到5.0598亿美元。

胞外体是细胞外囊泡，在细胞间的通讯中发挥重要作用，在药物传递、诊断和再生医学等各种科学和医学领域受到关注。特别是，它在药物传输、诊断和再生医学等各个科学和医学领域引起了人们的关注。它们的范围可实现治疗应用，作为生物活性分子的天然载体，并在标靶药物传输和诊断中用作疾病生物标记。胞外体研究的需求源于其透过提供有效治疗癌症和神经系统疾病等复杂疾病的尖端解决方案而彻底改变精准医学的潜力。关键的最终用途领域包括製药、生物技术和临床环境，我们利用我们的能力来改善患者的治疗结果。对非侵入性诊断的需求不断增长以及对个人化医疗的兴趣对市场产生了重大影响。分离和表征技术的技术进步扩大了研究可能性并推动了该领域的成长。加强胞外体精製方法并扩大其在化妆品和抗衰老产品中的用途存在机会。学术机构和生技公司之间的合作可以进一步加速创新。然而，高研究成本和监管障碍等挑战可能会阻碍市场成长。此外，胞外体分离和分析的标准化具有复杂的限制。对于公司而言，开发具有成本效益的分离技术以及提高胞外体产量和纯度的创新将是一个利润丰厚的领域。此外，探索胞外体的膜工程和货物装载可能会开闢新的治疗途径。市场充满活力，研发投资的增加和策略联盟的推动推动了进步。继续研究胞外体的生物学作用和功能对于解决现有的限制至关重要。最终，促进研究人员和行业相关人员之间的合作将有助于克服挑战，最大限度地发挥胞外体技术在不同应用中的潜力，并确保可持续的市场扩张和技术进步极为重要。

主要市场统计
基准年[2023] 23098万美元
预计年份 [2024] 2.574 亿美元
预测年份 [2030] 50598万美元
复合年增长率（%） 11.85%

市场动态：揭示快速发展的胞外体研究市场的关键市场洞察

胞外体研究市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病和遗传性疾病盛行率上升
    • 药物发现和开发活动的扩展以及对有效药物和基因发行策略的需求
    • 推动基因组和胞外体研究的政府津贴和倡议
  • 市场限制因素
    • 需要复杂先进的设备而缺乏熟练的人才
  • 市场机会
    • 透过整合尖端技术简化和加速胞外体研究
    • 患者对个人化医疗策略的偏好
  • 市场问题
    • 胞外体研究的技术限制与困难

波特五力：开拓胞外体研究市场的策略工具

波特的五力架构是了解胞外体研究市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胞外体研究市场的外部影响

外部宏观环境因素在塑造胞外体研究市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解胞外体研究市场的竞争格局

胞外体研究市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：胞外体研究市场供应商的绩效评估

FPNV定位矩阵是评估胞外体研究市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製胞外体研究市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，胞外体研究市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和遗传性疾病盛行率上升
      • 扩大药物发现和开发活动以及对有效药物和基因递送策略的需求
      • 推动基因组和胞外体研究的政府津贴和倡议
    • 抑制因素
      • 需要复杂先进的设备而缺乏熟练的人才
    • 机会
      • 融合先进技术，实现效率与速度
      • 患者对个人化医疗策略的偏好
    • 任务
      • 胞外体研究的技术限制与困难
  • 市场区隔分析
    • 产品/服务：用于诊断和治疗的胞外体研究服务变得越来越重要
    • 适应症：癌症检测胞外体研究的进展
    • 应用：胞外体研究在疫苗开发的广泛应用
    • 最终用户：将胞外体研究用于医院和临床环境中的诊断目的
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章胞外体研究市场：依产品及服务分类

  • 介绍
  • 装置
  • 试剂套件和试剂
  • 服务

第七章胞外体研究市场：依适应症分类

  • 介绍
  • 癌症适应症
    • 乳癌
    • 大肠直肠癌
    • 肺癌
    • 摄护腺癌
  • 心血管疾病
  • 感染疾病
  • 神经退化性疾病

第八章胞外体研究市场：依应用分类

  • 介绍
  • 生物标誌物
  • 组织再生
  • 疫苗开发

第 9 章胞外体研究市场：依最终使用者分类

  • 介绍
  • 学术研究所
  • 医院和临床实验室
  • 製药和生物技术公司

第10章 美洲胞外体研究市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太胞外体研究市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的胞外体研究市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Coya Therapeutics 和休士顿卫理公会研究所开创了对抗神经退化性疾病的胞外体研究
    • Promega 和 INOVIQ Ltd. 合作，利用先进的胞外体工具和人工智慧行销来改变癌症生物标记研究
    • Creative Proteomics推出先进的胞外体分离与精製服务
    • 总部位于南卡罗来纳州的 IMCS 与 Tymora Analytical 合作简化胞外体研究
    • AGC Biologics 与慈惠医科大学签署特发性肺纤维化 (IPF)计划胞外体协议
  • 战略分析和建议

公司名单

  • Abcam PLC by Danaher Corporation
  • Alpha Laboratories by Pace Analytical Services
  • AMS BIoTechnology（Europe）Limited
  • AMSBIO
  • BioCat GmbH by AddLife
  • Creative Biolabs
  • Cusabio Technology LLC
  • Fujifilm Holdings Corporation
  • HiSS Diagnostics GmbH
  • Lonza Group Ltd.
  • Malvern Panalytical Ltd.
  • MBL International Corporation
  • Miltenyi BIoTec BV & Co. KG
  • NanoSomiX, Inc.
  • Norgen BIoTek Corp.
  • Nx Pharmagen Inc.
  • QIAGEN NV
  • System Biosciences, LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-AD36CD897B3A

The Exosome Research Market was valued at USD 230.98 million in 2023, expected to reach USD 257.40 million in 2024, and is projected to grow at a CAGR of 11.85%, to USD 505.98 million by 2030.

Exosomes are extracellular vesicles playing key roles in cell communication and are gaining prominence in various scientific and medical fields, notably in drug delivery, diagnostics, and regenerative medicine. Their scope involves acting as natural carriers of bioactive molecules, enabling applications in therapeutics, where they are harnessed for targeted drug delivery and disease biomarkers in diagnostics. The necessity of exosome research stems from its potential to revolutionize precision medicine, offering cutting-edge solutions to effectively treat complex diseases like cancer and neurological disorders. Key end-use sectors include pharmaceuticals, biotechnology, and clinical settings that leverage their capabilities to enhance patient care outcomes. The market is significantly influenced by the rising need for non-invasive diagnostics and interest in personalized medicine. Technological advancements in isolation and characterization techniques amplify research possibilities, facilitating growth in this field. Opportunities lie in enhancing exosome purification methods and expanding their use in cosmeceuticals and anti-aging products. Collaborations between academic institutions and biotech firms could further accelerate innovation. However, challenges like the high cost of research and regulatory hurdles can impede market growth. Additionally, complexities in standardizing exosome isolation and analysis present limitations. For businesses, innovation in the development of cost-effective isolation techniques and enhancing the yield and purity of exosomes represent lucrative areas. Furthermore, exploring exosome membrane engineering and cargo loading could open new therapeutic avenues. The market is dynamic, with increasing R&D investments and strategic partnerships catalyzing progress. Continued research into the biological roles and functions of exosomes is essential to address existing limitations. Ultimately, fostering collaboration between researchers and industry players will be crucial in navigating challenges and unlocking the full potential of exosome technologies in diverse applications, ensuring sustainable market expansion and technological advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 230.98 million
Estimated Year [2024] USD 257.40 million
Forecast Year [2030] USD 505.98 million
CAGR (%) 11.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Exosome Research Market

The Exosome Research Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic disease conditions and genetic disorders
    • Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
    • Government grants and initiatives to advance genome and exosome research
  • Market Restraints
    • Need for complex and sophisticated equipment and lack of skilled personnel
  • Market Opportunities
    • Integration of advanced technologies to streamline and accelerate exosome research
    • Patient preference for personalized medicine strategies
  • Market Challenges
    • Technical limitations and difficulties of exosome research

Porter's Five Forces: A Strategic Tool for Navigating the Exosome Research Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Exosome Research Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Exosome Research Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Exosome Research Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Exosome Research Market

A detailed market share analysis in the Exosome Research Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Exosome Research Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Exosome Research Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Exosome Research Market

A strategic analysis of the Exosome Research Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Exosome Research Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Alpha Laboratories by Pace Analytical Services, AMS Biotechnology (Europe) Limited, AMSBIO, BioCat GmbH by AddLife, Creative Biolabs, Cusabio Technology LLC, Fujifilm Holdings Corporation, HiSS Diagnostics GmbH, Lonza Group Ltd., Malvern Panalytical Ltd., MBL International Corporation, Miltenyi Biotec B.V. & Co. KG, NanoSomiX, Inc., Norgen Biotek Corp., Nx Pharmagen Inc., QIAGEN N.V., System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Exosome Research Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Instruments, Kits & Reagents, and Services.
  • Based on Indication, market is studied across Cancer Indication, Cardiovascular Diseases, Infectious Diseases, and Neurodegenerative Diseases. The Cancer Indication is further studied across Breast Cancer, Colorectal Cancer, Lung Cancer, and Prostate Cancer.
  • Based on Application, market is studied across Biomarkers, Tissue Regeneration, and Vaccine Development.
  • Based on End User, market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease conditions and genetic disorders
      • 5.1.1.2. Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
      • 5.1.1.3. Government grants and initiatives to advance genome and exosome research
    • 5.1.2. Restraints
      • 5.1.2.1. Need for complex and sophisticated equipment and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies to streamline and accelerate exosome research
      • 5.1.3.2. Patient preference for personalized medicine strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and difficulties of exosome research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications
    • 5.2.2. Indication: Advancements in exosome research for cancer detection
    • 5.2.3. Application: Broad applications of exosome research for vaccine development
    • 5.2.4. End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Exosome Research Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Reagents
  • 6.4. Services

7. Exosome Research Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer Indication
    • 7.2.1. Breast Cancer
    • 7.2.2. Colorectal Cancer
    • 7.2.3. Lung Cancer
    • 7.2.4. Prostate Cancer
  • 7.3. Cardiovascular Diseases
  • 7.4. Infectious Diseases
  • 7.5. Neurodegenerative Diseases

8. Exosome Research Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarkers
  • 8.3. Tissue Regeneration
  • 8.4. Vaccine Development

9. Exosome Research Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Testing Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Exosome Research Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Exosome Research Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Exosome Research Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Coya Therapeutics and Houston Methodist Research Institute Pioneer Exosome Research to Battle Neurodegenerative Diseases
    • 13.3.2. Promega and INOVIQ Ltd. Team Up to Transform Cancer Biomarker Research with Advanced Exosome Tools and AI Marketing
    • 13.3.3. Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
    • 13.3.4. South Carolina-Based IMCS, Tymora Analytical Partner To Streamline Exosome Research
    • 13.3.5. AGC Biologics Signs Exosome Agreement with The Jikei University in Japan for Idiopathic Pulmonary Fibrosis (IPF) Project
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Alpha Laboratories by Pace Analytical Services
  • 3. AMS Biotechnology (Europe) Limited
  • 4. AMSBIO
  • 5. BioCat GmbH by AddLife
  • 6. Creative Biolabs
  • 7. Cusabio Technology LLC
  • 8. Fujifilm Holdings Corporation
  • 9. HiSS Diagnostics GmbH
  • 10. Lonza Group Ltd.
  • 11. Malvern Panalytical Ltd.
  • 12. MBL International Corporation
  • 13. Miltenyi Biotec B.V. & Co. KG
  • 14. NanoSomiX, Inc.
  • 15. Norgen Biotek Corp.
  • 16. Nx Pharmagen Inc.
  • 17. QIAGEN N.V.
  • 18. System Biosciences, LLC
  • 19. Takara Bio Inc.
  • 20. Thermo Fisher Scientific Inc.
  • 21. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. EXOSOME RESEARCH MARKET RESEARCH PROCESS
  • FIGURE 2. EXOSOME RESEARCH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXOSOME RESEARCH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXOSOME RESEARCH MARKET DYNAMICS
  • TABLE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023